Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Multiple Myeloma

Known as: Myeloma Multiple, multiple myeloma (MM), multiple myelomatosis 
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND Selinexor, a selective inhibitor of nuclear export compound that blocks exportin 1 (XPO1) and forces nuclear… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Review
2019
Review
2019
Recent advances in the treatment of multiple myeloma have increased the need for accurate diagnosis of the disease. The detection… Expand
Is this relevant?
Review
2019
Review
2019
The ubiquitin proteasome system (UPS) degrades individual proteins in a highly regulated fashion and is responsible for the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2019
Review
2019
Resveratrol is a polyphenolic nutraceutical that exhibits pleiotropic activities in human subjects. The efficacy, safety, and… Expand
Is this relevant?
Review
2019
Review
2019
Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment for hematologic malignancies. Two CAR T-cell… Expand
Is this relevant?
Review
2014
Review
2014
This International Myeloma Working Group consensus updates the disease definition of multiple myeloma to include validated… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Treatments for myeloma have expanded in the last decade, but it is not clear if the introduction of novel therapies and the… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
New uniform response criteria are required to adequately assess clinical outcomes in myeloma. The European Group for Blood and… Expand
  • table 3
  • table 5
  • table 6
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Background The median survival of patients with myeloma after conventional chemotherapy is three years or less. Promising results… Expand
Is this relevant?
Highly Cited
1975
Highly Cited
1975
The presenting clinical features of 71 patients with multiple myeloma were correlated with myeloma cell mass (myeloma cells X 10… Expand
Is this relevant?